NCT00488878
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Low Grade Ovarian Serous Adenocarcinoma
Explore clinical trials studying Low Grade Ovarian Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Low Grade Ovarian Serous Adenocarcinoma trial results
Completed
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
NCT00551070
- Conditions
- Adenocarcinoma, Borderline Ovarian Serous Tumor, Carcinoma, +11 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
Active, Not Recruiting
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
NCT06494150
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
Active, Not Recruiting
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation
NCT04625270
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Arizona Oncology Associates PC HAL Scottsdale, Arizona, United States
- Sansum Clinic Santa Barbara, California, United States
- Yale School of Medicine New Haven, Connecticut, United States
- Advent Health Orlando, Florida, United States